WallStreetZenWallStreetZen

NASDAQ: ASTH
Astrana Health Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Astrana Health earnings were $40.5M for the trailing 12 months ending Jun 30, 2026, with 56.6% growth year over year. The latest ASTH earnings report on Jun 30, 2026 announced Q2 2026 earnings of $19.7M, up 36.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ASTH reported annual earnings of $22.5M, with -47.9% growth. The next ASTH earnings date is Nov 5, 2026.

ASTH past earnings growth

How has ASTH's earnings growth performed historically?

Company
56.6%
Industry
50.8%
Market
92.59%
ASTH's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
ASTH's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
ASTH's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

ASTH earnings history

Current Revenue
$3.8B
Current Earnings
$40.5M
Current Profit Margin
1.1%

ASTH Return on Equity

Current Company
5.1%
Current Industry
-45%
Current Market
31%
ASTH's Return on Equity (5.1%)... subscribe to Premium to read more.
High Return on Equity Performance

ASTH Return on Assets

Current Company
1.8%
Current Industry
6.6%
ASTH is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ASTH announces earnings.

ASTH Return on Capital Employed

Current Company
8.39%
Current Industry
13.1%
ASTH's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ASTH vs Medical Care Facility Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ASTH$200.00M$40.55M-8.86%$0.83
ADUS$167.37M$105.31M+19.06%$5.79
MD$283.42M$174.81M+10.67%$2.13
CMPS-$389.35M-$394.19MN/A-$3.60
SNDA$26.16M-$145.36MN/A-$6.19
View Top Medical Care Facility Stocks

ASTH earnings dates

Next earnings date
Nov 5, 2026

Astrana Health Earnings Reports & History FAQ

What were Astrana Health's earnings last quarter?

On ASTH's earnings call on Aug 6, 2026, Astrana Health (NASDAQ: ASTH) reported Q2 2026 earnings per share (EPS) of $0.40, up 110.53% year over year. Total ASTH earnings for the quarter were $19.74 million. In the same quarter last year, Astrana Health's earnings per share (EPS) was $0.19.

If you're new to stock investing, here's how to buy Astrana Health stock.

When does Astrana Health report earnings?

The next ASTH earnings date is Nov 5, 2026. Add ASTH to your watchlist to be reminded of Astrana Health's next earnings date.

Is Astrana Health profitable or losing money?

As of the last Astrana Health earnings report, Astrana Health is currently profitable. Astrana Health's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $40.55 million, a 60.53% increase year over year.

What was ASTH's earnings growth in the past year?

As of Astrana Health's earnings date in Aug 6, 2026, Astrana Health's earnings has grown 56.6% year over year. This is 5.8 percentage points higher than the US Medical Care Facilities industry earnings growth rate of 50.8%. ASTH earnings in the past year totalled $40.55 million.

What are Astrana Health's earnings expectations?

The current EPS estimate for Astrana Health's earnings report in Nov 5, 2026 is $0.42.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.